Investors in Lausanne, Switzerland
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Foundation for Innovation and Technology (FIT) | Entrepreneurship program | Lausanne, Switzerland | •••@fondation-fit.ch | +41 21••• |
| Polytech Ventures | Micro VC fund | Lausanne, Switzerland | •••@polytechventure.lu | 0041 2••• |
| Debiopharm Innovation Fund | Venture capital firm | Lausanne, Switzerland | •••@debiopharm.com | 418-65••• |
| HackCapital | Venture capital firm | Lausanne, Switzerland | •••@hackcapital.co | |
| 4FOX Ventures | Venture capital firm | Lausanne, Switzerland | •••@4fox-ventures.com | +41 22••• |
| VINCI CAPITAL | Private equity firm | Lausanne, Switzerland | •••@renaissance.swiss | +41 (0••• |
| Changer Club | Angel group | Lausanne, Switzerland | •••@clubchanger.com | +371 2••• |
| C Capital | Hedge fund | Lausanne, Switzerland | •••@youngtimers.com | 41 615••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 17 of the 40 investors in Lausanne, Switzerland have a published email address, 14 a phone number and 32 a website.
- Foundation for Innovation and Technology (FIT) has the most recorded investments, 345, 329 of them as lead investor.
- 7 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Foundation for Innovation and Technology (FIT) is an investor in 7 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Altis Labs' $25.0M Series A on 17 September 2026.
- Software is the most common sector across their 59 portfolio companies (54%).
- Seed is the most common investment stage, recorded for 21 of them (52%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Investors in Lausanne, Switzerland
30 of 40, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Foundation for Innovation and Technology (FIT) | Entrepreneurship program, Government investment office | Lausanne, Switzerland | Health care, Biotech | Adaptyv Biosystems, Carewell, Alithea Genomics | 7 | 345 | 329 | 35 | •••@fondation-fit.ch | +41 21••• | In the CSV |
| 2 | Polytech Ventures | Micro VC fund | Lausanne, Switzerland | Fintech, Commerce | NetGuardians, yamo, Saphetor | 45 | 10 | 16 | •••@polytechventure.lu | 0041 2••• | In the CSV | |
| 3 | Debiopharm Innovation Fund | Venture capital firm | Lausanne, Switzerland | Health care, Biotech | Altis Labs | 1 | 36 | 19 | 9 | •••@debiopharm.com | 418-65••• | In the CSV |
| 4 | Future of Health Grant | Startup accelerator | Lausanne, Switzerland | Health care | Bewelab SA | 1 | 33 | 30 | 0 | In the CSV | ||
| 5 | IMD Startup Competition | Startup competition | Lausanne, Switzerland | Energy | Swisspod | 1 | 28 | 28 | 0 | +41 21••• | In the CSV | |
| 6 | HackCapital | Venture capital firm | Lausanne, Switzerland | Biotech, Commerce | Omni | 1 | 25 | 1 | 1 | •••@hackcapital.co | In the CSV | |
| 7 | 4FOX Ventures | Venture capital firm | Lausanne, Switzerland | 19 | 10 | 0 | •••@4fox-ventures.com | +41 22••• | In the CSV | |||
| 8 | VINCI CAPITAL | Private equity firm | Lausanne, Switzerland | Biotech, Health care | Anergis | 15 | 4 | 8 | •••@renaissance.swiss | +41 (0••• | In the CSV | |
| 9 | Changer Club | Angel group, Syndicate | Lausanne, Switzerland | Biotech, Hardware | Memic Innovative Surgery | 15 | 0 | 3 | •••@clubchanger.com | +371 2••• | In the CSV | |
| 10 | Skyviews Life Science | Venture capital firm | Lausanne, Switzerland | Biotech | MIRAI FOODS | 13 | 0 | 1 | In the CSV | |||
| 11 | C Capital | Hedge fund, Private equity firm | Lausanne, Switzerland | 12 | 4 | 0 | •••@youngtimers.com | 41 615••• | In the CSV | |||
| 12 | PM Equity Partner | Corporate venture arm, Private equity firm | Lausanne, Switzerland | Health care, Biotech | Biognosys, Biovotion | 11 | 8 | 2 | •••@pmi.com | +41 58••• | In the CSV | |
| 13 | SwissBorg | Venture capital firm | Lausanne, Switzerland | Fintech | Phaver, D8X | 7 | 0 | 0 | •••@swissborg.com | In the CSV | ||
| 14 | EPFL Startup Launchpad | Startup incubator | Lausanne, Switzerland | Artificial intelligence, Hardware | MIROS Technology | 1 | 5 | 5 | 0 | In the CSV | ||
| 15 | Swiss Diabetes Venture Fund | Venture capital firm | Lausanne, Switzerland | 5 | 3 | 0 | In the CSV | |||||
| 16 | Rewired | Micro VC fund | Lausanne, Switzerland | 5 | 1 | 1 | •••@rewired.com | In the CSV | ||||
| 17 | Luca Merolla | Angel investor | Lausanne, Switzerland | 5 | 0 | 0 | In the CSV | |||||
| 18 | DEFI Gestion | Venture capital firm | Lausanne, Switzerland | Biotech, Health care | NanoPowers | 4 | 0 | 2 | •••@defigestion.ch | +41 21••• | ||
| 19 | AtmosClear Investments | Private equity firm, Venture capital firm | Lausanne, Switzerland | 3 | 1 | 0 | •••@atmosclear.com | +41219••• | In the CSV | |||
| 20 | Rewired.GG | Venture capital firm | Lausanne, Switzerland | 2 | 2 | 0 | In the CSV | |||||
| 21 | Edouard Lambelet | Angel investor | Lausanne, Switzerland | 2 | 1 | 1 | In the CSV | |||||
| 22 | Banque Cantonale Vaudoise | Investment bank | Lausanne, Switzerland | 2 | 0 | 0 | 0844 2••• | In the CSV | ||||
| 23 | Enrico Bruschini | Angel investor | Lausanne, Switzerland | Artificial intelligence | Userbot | 2 | 0 | 0 | In the CSV | |||
| 24 | EPFL Alumni | Startup competition | Lausanne, Switzerland | 1 | 1 | 0 | •••@epfl.ch | +41 (0••• | In the CSV | |||
| 25 | Prix Strategis | Entrepreneurship program | Lausanne, Switzerland | 1 | 1 | 0 | +41 21••• | In the CSV | ||||
| 26 | Bogdan Manoiu | Angel investor | Lausanne, Switzerland | Software | iRewind | 1 | 0 | 1 | In the CSV | |||
| 27 | Salus Partners SA | Private equity firm | Lausanne, Switzerland | 1 | 0 | 1 | In the CSV | |||||
| 28 | Manh'al Fund | Fund of funds, Private equity firm | Lausanne, Switzerland | 0 | 0 | 0 | •••@manhalfund.com | In the CSV | ||||
| 29 | Mikhail Kokorich | Lausanne, Switzerland | 0 | 0 | 0 | In the CSV | ||||||
| 30 | Olivier Laplace | Investment partner | Lausanne, Switzerland | 0 | 0 | 0 | In the CSV |
Table 1. Investors in Lausanne, Switzerland: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 40.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Foundation for Innovation and Technology (FIT) | Lausanne, Switzerland | 7 | 30 | Adaptyv Biosystems, Carewell, Alithea Genomics |
| 2 | Debiopharm Innovation Fund | Lausanne, Switzerland | 1 | 6 | Altis Labs |
| 3 | Future of Health Grant | Lausanne, Switzerland | 1 | 2 | Bewelab SA |
| 4 | HackCapital | Lausanne, Switzerland | 1 | 3 | Omni |
| 5 | Dominique Vidal | Lausanne, Switzerland | 1 | 1 | HrFlow.ai |
| 6 | EPFL Startup Launchpad | Lausanne, Switzerland | 1 | 1 | MIROS Technology |
| 7 | IMD Startup Competition | Lausanne, Switzerland | 1 | 1 | Swisspod |
Table 2. Investors in Lausanne, Switzerland: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Altis Labs | Altis Labs uses AI endpoints to speed clinical trials so new treatments reach patients sooner. | Artificial intelligence | Toronto, Canada | Series A | $25.0M | 2026-09-17 | $31.0M | Debiopharm Innovation Fund | 11 to 50 | 2019 |
| Adaptyv Biosystems | Adaptyv Biosystems develops protein engineering tools using cell-free synthetic biology and nanofluidics technology. | Artificial intelligence | Lausanne, Switzerland | Series A | $40.0M | 2026-08-25 | $50.9M | Foundation for Innovation and Technology (FIT) | 11 to 50 | 2020 |
| Bewelab SA | Bewelab SA uses neuroscience-based digital interventions to reduce cravings at the neural level. | Health care | Fribourg, Switzerland | Seed | $2.5M | 2026-08-19 | $5.5M | Future of Health Grant | 1 to 10 | 2021 |
| Carewell | Carewell connects caregivers with flexible work opportunities through a marketplace platform. | Health care | Pully, Switzerland | Seed | $1.9M | 2026-07-03 | $2.4M | Foundation for Innovation and Technology (FIT) | 1 to 10 | 2024 |
| Omni | Omni develops plant-based dog food that is healthy and sustainable. | Commerce | London, United Kingdom | Series A | $14.6M | 2026-06-22 | $17.4M | HackCapital | 1 to 10 | 2019 |
| MIROS Technology | MIROS Technology operates a workspace platform giving on-demand access to workspaces through a mobile application. | Artificial intelligence | Lausanne, Switzerland | Pre-seed | $1.3M | 2026-03-30 | $1.6M | EPFL Startup Launchpad | 1 to 10 | 2023 |
| Alithea Genomics | Alithea Genomics develops molecular biology tools and sequencing solutions for large-scale gene expression analysis. | Biotech | Lausanne, Switzerland | Seed | $3.8M | 2026-03-04 | $9.9M | Foundation for Innovation and Technology (FIT) | 11 to 50 | 2020 |
| Algorized | Algorized develops software that detects people, locates them, and senses vital signs using existing wireless sensors. | Artificial intelligence | Lausanne, Switzerland | Series A | $13.0M | 2026-02-10 | $17.3M | Foundation for Innovation and Technology (FIT) | 11 to 50 | 2024 |
| Genknowme | Genknowme is a precision health company advancing epigenetics to support personalized and preventive care. | Biotech | Lausanne, Switzerland | Pre-seed | $630K | 2025-12-18 | $947K | Foundation for Innovation and Technology (FIT) | 1 to 10 | 2019 |
| Swisspod | Swisspod develops energy-efficient hyperloop systems for high-speed transportation. | Energy | Monthey, Switzerland | Seed | $13.0M | 2025-11-25 | $25.5M | IMD Startup Competition | 101 to 250 | 2019 |
Table 3. Investors in Lausanne, Switzerland: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 32 | 54% |
| Health care | 24 | 41% |
| Biotech | 18 | 31% |
| Artificial intelligence | 13 | 22% |
| Hardware | 12 | 20% |
| Fintech | 5 | 8% |
| Commerce | 5 | 8% |
| Cybersecurity | 3 | 5% |
| Energy | 2 | 3% |
| Education | 1 | 2% |
Table 4. Investors in Lausanne, Switzerland: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Seed investors | 21 | 52% |
| Early stage investors | 15 | 38% |
| Late stage investors | 8 | 20% |
| Venture investors | 5 | 12% |
| Grant makers | 5 | 12% |
| Private equity investors | 5 | 12% |
| Non equity assistance | 1 | 2% |
| Secondary market investors | 1 | 2% |
Table 5. Investors in Lausanne, Switzerland by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 3 | 13% |
| 2010s | 11 | 48% |
| 2000s | 3 | 13% |
| 1990s | 4 | 17% |
| 1850s | 1 | 4% |
| 1840s | 1 | 4% |
Table 6. Investors in Lausanne, Switzerland by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its headquarters is in Lausanne, Switzerland. On 16 November 2026 that is 40 investors.
- 17 rows carry an email address and 14 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 40 rows: 8 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many investors in Lausanne, Switzerland are on the list?
- 40, in the file dated 16 November 2026. 7 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 17 of the 40 carry an email address in the download and 14 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 40 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 40 rows, 17 firm email addresses and 14 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 9 of the 17 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.